India's renowned Serum Institute, known for its pivotal role in producing COVID-19 vaccines, is now setting its sights on addressing other pressing global health challenges. The institute has announced plans to develop new vaccines targeting malaria and dengue, two diseases that continue to pose significant threats to public health.
With its proven track record in vaccine development and production, the Serum Institute is well-positioned to make a meaningful impact in the fight against malaria and dengue. These new vaccines have the potential to save countless lives and reduce the burden of these diseases on healthcare systems worldwide.
